SCHEMBL6972221

SCHEMBL6972221

COC(=O)c1ccc(NS(=O)(=O)c2ccc(F)cc2)c(OC)c1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.64
CYP2C9 P11712 5/20 0.64
KDM4E B2RXH2 5/20 0.60
TSHR P16473 2/20 0.57
NPSR1 Q6W5P4 1/20 0.57
POLB P06746 1/20 0.56
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
LMNA P02545 3/20 0.53
MAPT P10636 2/20 0.53
HPGD P15428 2/20 0.53
CASP1 P29466 1/20 0.51
CASP7 P55210 1/20 0.51
HSD17B10 Q99714 1/20 0.51
MRGPRX1 Q96LB2 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7569777 0.88 CYP2C9 (0.64) ALDH1A1CYP2C9KDM4ETSHRNPSR1
SCHEMBL25072992 0.87 CYP2C9 (0.64) ALDH1A1CYP2C9KDM4ETSHRNPSR1
SCHEMBL1138924 0.87 CYP2C9 (0.63) ALDH1A1CYP2C9KDM4ETSHRNPSR1
SCHEMBL25072986 0.86 KDM4E (0.63) ALDH1A1KDM4EPOLBKMT2AMEN1
SCHEMBL6978287 0.86 CYP2C9 (0.64) ALDH1A1CYP2C9KDM4ETSHRNPSR1
SCHEMBL25073092 0.84 ALDH1A1 (0.56) ALDH1A1CYP2C9KDM4ETSHRNPSR1
SCHEMBL30278430 0.84 ALDH1A1 (0.56) ALDH1A1CYP2C9KDM4ETSHRNPSR1
SCHEMBL25072525 0.81 MAPT (0.53) ALDH1A1CYP2C9KDM4ETSHRNPSR1
SCHEMBL23380710 0.81 CYP2C9 (0.61) ALDH1A1CYP2C9KDM4ETSHRNPSR1
SCHEMBL25072957 0.80 KDM4E (0.56) ALDH1A1KDM4EKMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed
EP-1109560-A4 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2002-04-17 EP disclosed
EP-1109560-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2001-06-27 EP disclosed
WO-2000013688-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2000-03-16 WO disclosed